Clinical Studies

Current Clinical Study

Now recruiting Canadian subjects & clinical sites for our Contino® Post Market Clinical Follow-up study.

The Contino® urethral insert is a non-surgical self-administered licensed medical device that controls bladder leakage in men. In the June 2020 edition of the Canadian Urology Association Journal (CUAJ) Contino® foundational clinical study was published.

Medical Device Manufacturing Canada

We are now enrolling male volunteers with urinary incontinence to participate in a post-market clinical follow-up study for the device.

If eligible to participate, you will be seen by a study doctor and will receive study-related testing and the device at no cost. If enrolled, you may be reimbursed for parking and travel expenses.

You may be eligible if:

  • you are male, 18 years of age or older; and
  • you have evidence of moderate to severe urinary incontinence

There will be six visits to the study doctor’s office over the course of one year.

To see if you are an eligible candidate, complete this questionnaire or visit myconti.no/study.

You may also contact the CMX Research Patient Recruitment Centre at 1 (866) 666-3329 or by email at trials@cmxres.com

Top